Cannimed Therapeutics Inc (CMED.CA) Stock Price, Forecast & Analysis
Canada - Toronto Stock Exchange - TSX:CMED -
CMED.CA Key Statistics, Chart & Performance
The current stock price of CMED.CA is 27 null. In the past month the price decreased by -17.13%. In the past year, price increased by 138.94%.
About CMED.CA
Company Profile
CanniMed Therapeutics Inc is a biopharmaceutical company. The principal business activities of CanniMed along with its subsidiaries is plant biotechnology research, product development and the production of plant based materials.
Company Info
Cannimed Therapeutics Inc
1 Plant Technology Road
Saskatoon SK S7K 3J8
CEO: Brent Zettl
Phone: +1 855 787-1577
Cannimed Therapeutics Inc / CMED.CA FAQ
What does Cannimed Therapeutics Inc do?
CanniMed Therapeutics Inc is a biopharmaceutical company. The principal business activities of CanniMed along with its subsidiaries is plant biotechnology research, product development and the production of plant based materials.
What is the stock price of Cannimed Therapeutics Inc today?
The current stock price of CMED.CA is 27 null. The price decreased by -5.26% in the last trading session.
What is the dividend status of Cannimed Therapeutics Inc?
CMED.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of CMED stock?
CMED.CA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
How is the valuation of Cannimed Therapeutics Inc (CMED.CA) based on its PE ratio?
The PE ratio for Cannimed Therapeutics Inc (CMED.CA) is 245.45. This is based on the reported non-GAAP earnings per share of 0.11 and the current share price of 27 null.
Would investing in Cannimed Therapeutics Inc be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CMED.CA.
CMED.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to CMED.CA. When comparing the yearly performance of all stocks, CMED.CA is one of the better performing stocks in the market, outperforming 91.46% of all stocks.
CMED.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to CMED.CA. CMED.CA has an excellent financial health rating, but there are some minor concerns on its profitability.
CMED.CA Financial Highlights
Over the last trailing twelve months CMED.CA reported a non-GAAP Earnings per Share(EPS) of 0.11. The EPS increased by 103.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 15% | ||
| ROA | 2.18% | ||
| ROE | 2.76% | ||
| Debt/Equity | 0.1 |